Precision Medicine Conference 2016

submenu

Conference 2016 Completed

This year's Precision Medicine Conference had 300 attendees and the first 150 registrants were genotyped.

This conference presented current considerations and applications of genomics from national experts in pharmacogenomics who will discuss the status of precision medicine in the country, implementation into the clinical setting including incorporation of data into EMR and management of patients with these variants with an emphasis on psychiatry, cardiology and oncology applications.

Precision Medicine Conference
2016

Watch Speaker 2016 Presentation Videos!

Conference Objectives

  1. Raise awareness of the clinical utility of pharmacogenomics and increase enthusiasm for implementing pharmacogenomic testing in the clinic.
  2. Create a forum, with the help of local and national leaders in the field, for faculty to identify shared interests, foster research ideas and develop interdisciplinary collaborations.
  3. Encourage research collaborations in pharmacogenomic discoveries and clinical implementation.

Target Participants

Local and regional physicians, pharmacists, PhDs and hospital and clinic administrators. The public is welcome. 

Continuing Education

Continuing Education credits are being offered for pharmacists. The paperwork will be available at the conference for self-accreditation.

Support

This program is organized by the Institute of Personalized Medicine and Department of Experimental and Clinical Pharmacology in the College of Pharmacy, and the Precision Medicine and Health Consortium. 

Genotyping is provided by Agena Bioscience and DNA extraction by DNA Genotek.  Financial support is provided by the College of Pharmacy, Department of Experimental and Clinical Pharmacology, Masonic Cancer Center, University of Minnesota and OneOme and Assurex.

Agenda

7:30am- 8:30am
Networking/ Breakfast/ Poster Viewing

8:30am- 8:40am
Welcome to the conference
Marilyn Speedie, PhD

8:40am- 9:10am
Pharmacogenomics: The future is now
Pamala Jacobson, PharmD, FCCP

9:10am- 9:20am
Perspectives on Precision Medicine from Current Cancer Patient
Katherine Bensen, BA

9:20am- 9:25am
Introduction of  Dr. McCarty & Dr. Mueller
Jeffrey Bishop, PharmD, MS, BCPP

9:25am- l0:00am
The eMERGE PGx project: A multicenter pilot study of preemptive pharmacogenomics
Catherine McCarty, PhD, MPH, RD

10:00am- 10:35am
Toward Precision Medicine in Psychiatry: Current implementation strategies for antidepressant and antipsychotic medications
Daniel J. Mueller, MD

10:35am- 10:50am
Break/Coffee and poster viewing

10:50am- 10:55am
Introduction of  Dr. Stewart &  Dr. Caudle
Brian Van Ness, PhD

10:55am- 11:30am
Individualizing Cancer Therapy- the Mayo Clinic experience
Keith Stewart, MB, CHB

11:30am- 12:05pm
The Clinical Pharmacogenomics Implementation Consortium (CP IC): Incorporating pharmacogenomics into clinical practice and the electronic health record
Kelly Caudle, PharmD, PhD

12:05pm- 12:25pm
Panel Question & Answers
Morning Speakers and Moderated by Dr. Bishop and Dr. Van Ness

12:25pm- 12:55pm
Lunch

1:05pm- 1:50pm
Interpreting genotype results and case discussion
Brian Van Ness, PhD and Jeffrey Bishop, PharmD

1:50pm- 1:55pm
Introduction of Dr. Weitzel and Dr. Aliferis
Robert Straka, PharmD, FCCP

1:55pm- 2:30pm
Clinical Implementation of Pharmacogenomics: Clopidogrel example
Kristin Weitzel, PharmD, CDE, FAPhA

2:30pm- 3:05pm
Big data science for genomics and precision medicine
Constantin Aliferis, MD, PhD

3:05pm-3:20 pm
Break/Coffee and poster viewing

3:20pm-3:25pm
Introduction of Dr. Schondelmeyer and Dr. Pacanowski
Jacob Brown, PharmD, MSc

3:25pm-4:00pm
Pharmacogenomics: Why Bother? Who Pays? How Much?
Steve Schondelmeyer, PharmD

4:00pm- 4:35pm
Regulatory considerations for the next generation of medicines
Michael Pacanowski, PharmD, MPH

4:35pm-4:55pm
Panel Question & Answers
Afternoon Speakers and Moderated by Dr. Straka & Dr. Brown

4:55pm-5:00pm
Concluding Remarks
Pamala Jacobson, PharmD, FCCP

Speakers

Constantin AliferisConstantin Aliferis, MD, PhD

"Big data science for genomics and precision medicine"
Professor and Director of the Institute for Health Informatics, University of Minnesota, Minneapolis

Kelly CaudleKelly Caudle, PharmD, PhD, BCPS
"The Clinical Pharmacogenomics Implementation Consortium (CPIC): Incorporating pharmacogenomics into clinical practice and the electronic health record"
Clinical Pharmacogenetics Implementation Consortium (CPIC) Coordinator, St. Jude Children's Hospital and Assistant Professor, University of Tennessee, Memphis

Catherine McCartyCatherine McCarty, PhD, MPH, RD
"The eMERGE PGx project: A multicenter pilot study of pre-emptive pharmacogenomics"
Principal Research Scientist and Director of Research Division, Essentia Institute of Rural Health, Duluth

Daniel J. MuellerDaniel J. Mueller, MD, PhD
"Toward Precision Medicine in Psychiatry: Current implementation strategies for antidepressant and antipsychotic medications"
Associate Professor, Department of Psychiatry, University of Toronto, Toronto, Canada

Michael A. PacanowskiMichael A. Pacanowski, PharmD, MPH
"Regulatory considerations for the next generation of medicines"
Associate Director for Genomics and Targeted Therapy, Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Springs, Maryland

Stephen W. SchondelmeyerStephen W. Schondelmeyer, PharmD, PhD
"Pharmacogenomics: Why Bother? Who Pays? How Much?"
Head, Department of Pharmaceutical Care & Health Systems
Professor and Director, PRIME Institute
Endowed Chair in Pharmaceutical Management & Economics College of Pharmacy, University of Minnesota, Minneapolis

Keith StewartKeith Stewart, MB, CHB
"Individualizing Cancer Therapy - the Mayo Clinic Experience"
Director, Mayo Center for Individualized Medicine, Mayo Department of Hematology/Oncology, Arizona & Minnesota

Kristin WeitzelKristin Weitzel, PharmD, CDE, FAPhA
"Clinical Implementation of Pharmacogenomics: Clopidogrel example"
Clinical Associate Professor and Associate Director, Personalized Medicine Program, University of Florida, Gainesville

Genotyping

The first 150 conference registrants had the opportunity to submit a DNA sample prior to conference for their own personal pharmacogenomic panel with a lunchtime discussion on how these genotypes may affect their current and future medications. For more information on the PGx68 panel visit www.agenabio.com/products/panels/pharmacogenetics/.

Organizers

CONFERENCE DIRECTOR

Pamala JacobsonPamala Jacobson, PharmD, FCCP
Professor, Experimental and Clinical Pharmacology
Director of Institute of Personalized Medicine in the College of Pharmacy, University of Minnesota, Minneapolis

CONFERENCE ORGANIZERS

Jeffrey BishopJeffrey Bishop, PharmD, MS, BCPP
Associate Professor, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis

Jacob BrownJacob Brown, PharmD, MSc
Assistant Professor, Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth

Susan MarinoSusan Marino, PhD
Associate Professor, Department of Experimental and Clinical Pharmacology
Director, Center for Clinical and Cognitive Neuropharmacology College of Pharmacy, University of Minnesota, Minneapolis

Bill OettingBill Oetting, PhD
Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis


Robert StrakaRobert J. Straka, PharmD, FCCP
Department Head and Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis

Brian Van NessBrian Van Ness, PhD
Professor, Medical School Dept Genetics, Cell Biology & Development University of Minnesota, Minneapolis